ACM
BEAM icon

Aquatic Capital Management’s Beam Therapeutics BEAM Stock Holding History

Aquatic Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-54,953
Closed -$1.31M – 1273
2026
Q1 		$1.31M Buy
+54,953
New +$1.52M 0.04% 496
2024
Q3 		– Sell
-6,100
Closed -$143K – 1157
2024
Q2 		$143K Sell
6,100
-1,800
-23% -$44.2K 0.01% 830
2024
Q1 		$261K Buy
+7,900
New +$246K 0.01% 703
2023
Q2 		– Sell
-23,300
Closed -$713K – 1342
2023
Q1 		$713K Buy
23,300
+8,700
+60% +$343K 0.04% 338
2022
Q4 		$567K Buy
+14,600
New +$654K 0.04% 472

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Aquatic Capital Management's BEAM Position: Q2 2026 in Review

Aquatic Capital Management sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 54,953 shares — an estimated $1.31M sold.

Aquatic Capital Management first reported a position in BEAM in Q4 2022 and held it in 5 quarters. The position peaked at $1.31M in Q1 2026. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Aquatic Capital Management reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 54,953 Beam Therapeutics shares in Q2 2026, an estimated $1.31M.
  • Aquatic Capital Management first reported a position in Beam Therapeutics in Q4 2022 and held it in 5 quarters.
  • Aquatic Capital Management's Beam Therapeutics position peaked at $1.31M in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.